---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-068709"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2025-07-17T23:59:59+00:00"
generated_at: "2026-05-18T05:54:42.668638+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BrainStorm delisted from Nasdaq; shares to trade on OTCQB from July 18

## Summary
- Delisting due to non-compliance with Nasdaq minimum shareholder equity rule (Rule 5550(b)(1)).
- Nasdaq trading suspended at open on July 18, 2025; company received notice on July 16.
- Shares approved for OTCQB quotation under same symbol BCLI starting July 18.
- CEO states delisting does not alter mission; focus on NurOwn Phase 3b trial under SPA with FDA.
- Company confirms no impact on business operations or ongoing R&D efforts.

## SEC filing metadata
- accession: 0001104659-25-068709
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2025-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465925068709/0001104659-25-068709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465925068709/tm2521145d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-068709
- JSON: https://secwatch.observer/filing/0001104659-25-068709.json
- Plain text: https://secwatch.observer/filing/0001104659-25-068709.txt

## Source-grounded claims
- claim_id: f8d3240fc79524f6c9f5703a26c406b6dfdcf273
  claim: BRAINSTORM CELL THERAPEUTICS INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: July 16, 2025, Brainstorm Cell Therapeutics Inc. (the “ Company ”) was notified by The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of the Company’s previously disclosed noncompliance with Nasdaq Listing Rule 5550(b)(1), Nasdaq has determined to delist the Company’s common stock from the Nasdaq Capital Market and, accordingly, will suspend trading in the Company’s common stock effective at the open of trading on July 18, 2025. The Company has applied and been approved to have its common stock quoted on the OTC Markets’ OTCQB® market tier, an electronic quotation service operated by OT
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465925068709/0001104659-25-068709-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.